Report emphasizes that "None of the deaths were considered related to vaccination."
However, the last paragraph reads,
"However, the report did say that following the issuance of the emergency use authorization in December 2020, a number of cases of rare heart conditions, including myocarditis and pericarditis, were reported following vaccination, leading the FDA and CDC to identify "serious risks for myocarditis and pericarditis following administration of" the Pfizer vaccine. The risk factor appears to be higher in males under 40, the report added, with boys ages 12 to 17 being especially at risk."